COVID-19 Testing Boosts Roche Diagnostics Sales In H1

Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.

Roche

Roche Diagnostics' sales grew 3% during the first half of 2020 driven by demand for COVID-19 testing.

Roche Holding AG reported CHF 6.1bn ($6.47bn) sales in its diagnostics division during the first half of 2020 on 23 July. The company's molecular diagnostics business grew 61% year-over-year...

More from In Vitro Diagnostics

More from Diagnostics